Cerner Corporation (NASDAQ: CERN) Stock Competitors & Peer Comparison
See CERN's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CERN and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CERN | $94.92 | +0.00% | 0 | 55.84 | $1.70 | N/A |
| VEEV | $186.24 | +3.71% | 30.3B | 22.37 | $8.33 | N/A |
| GEHC | $60.58 | -2.27% | 27.6B | 13.29 | $4.56 | +0.23% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $72.91 | +4.40% | 14.3B | 58.80 | $1.24 | N/A |
| BTSGU | $238.26 | +3.48% | 14.2B | 215.44 | $1.11 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $94.64 | +0.33% | 7.9B | 22.11 | $4.28 | N/A |
| TEM | $42.69 | -7.22% | 7.5B | -85.38 | -$0.50 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
Stock Comparison
Veeva Systems Inc. (NYSE: VEEV)
CERN vs VEEV Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, VEEV has a market cap of 30.3B. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while VEEV trades at $186.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas VEEV's P/E ratio is 22.37. In terms of profitability, CERN's ROE is +0.14%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, CERN is less volatile compared to VEEV. This indicates lower risk in terms of short-term price fluctuations for CERN.Check VEEV's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
CERN vs GEHC Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, GEHC has a market cap of 27.6B. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while GEHC trades at $60.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas GEHC's P/E ratio is 13.29. In terms of profitability, CERN's ROE is +0.14%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, CERN is less volatile compared to GEHC. This indicates lower risk in terms of short-term price fluctuations for CERN.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
CERN vs GEHCV Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas GEHCV's P/E ratio is N/A. In terms of profitability, CERN's ROE is +0.14%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, CERN is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for CERN.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
CERN vs BTSG Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, BTSG has a market cap of 14.3B. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while BTSG trades at $72.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas BTSG's P/E ratio is 58.80. In terms of profitability, CERN's ROE is +0.14%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, CERN is less volatile compared to BTSG. This indicates lower risk in terms of short-term price fluctuations for CERN.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
CERN vs BTSGU Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, BTSGU has a market cap of 14.2B. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while BTSGU trades at $238.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas BTSGU's P/E ratio is 215.44. In terms of profitability, CERN's ROE is +0.14%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, CERN is less volatile compared to BTSGU. This indicates lower risk in terms of short-term price fluctuations for CERN.Check BTSGU's competition here
Signify Health, Inc. (NYSE: SGFY)
CERN vs SGFY Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas SGFY's P/E ratio is 70.91. In terms of profitability, CERN's ROE is +0.14%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, CERN is similarly volatile compared to SGFY. This indicates similar risk in terms of short-term price fluctuations for CERN.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
CERN vs HQY Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, HQY has a market cap of 7.9B. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while HQY trades at $94.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas HQY's P/E ratio is 22.11. In terms of profitability, CERN's ROE is +0.14%, compared to HQY's ROE of +0.11%. Regarding short-term risk, CERN is less volatile compared to HQY. This indicates lower risk in terms of short-term price fluctuations for CERN.Check HQY's competition here
Tempus AI, Inc. (NASDAQ: TEM)
CERN vs TEM Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, TEM has a market cap of 7.5B. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while TEM trades at $42.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas TEM's P/E ratio is -85.38. In terms of profitability, CERN's ROE is +0.14%, compared to TEM's ROE of -0.70%. Regarding short-term risk, CERN is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for CERN.Check TEM's competition here
R1 RCM Inc. (NASDAQ: RCM)
CERN vs RCM Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, RCM has a market cap of 6B. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas RCM's P/E ratio is -102.21. In terms of profitability, CERN's ROE is +0.14%, compared to RCM's ROE of +0.00%. Regarding short-term risk, CERN is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for CERN.Check RCM's competition here
10x Genomics, Inc. (NASDAQ: TXG)
CERN vs TXG Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, TXG has a market cap of 5.9B. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while TXG trades at $46.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas TXG's P/E ratio is -272.18. In terms of profitability, CERN's ROE is +0.14%, compared to TXG's ROE of -0.03%. Regarding short-term risk, CERN is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for CERN.Check TXG's competition here
Hinge Health, Inc. (NYSE: HNGE)
CERN vs HNGE Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, HNGE has a market cap of 5.8B. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while HNGE trades at $74.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas HNGE's P/E ratio is 38.12. In terms of profitability, CERN's ROE is +0.14%, compared to HNGE's ROE of -1.39%. Regarding short-term risk, CERN is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for CERN.Check HNGE's competition here
Doximity, Inc. (NYSE: DOCS)
CERN vs DOCS Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, DOCS has a market cap of 3.8B. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while DOCS trades at $20.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas DOCS's P/E ratio is 13.35. In terms of profitability, CERN's ROE is +0.14%, compared to DOCS's ROE of +0.19%. Regarding short-term risk, CERN is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for CERN.Check DOCS's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
CERN vs ONEM Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas ONEM's P/E ratio is -7.77. In terms of profitability, CERN's ROE is +0.14%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, CERN is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for CERN.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
CERN vs PRVA Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, PRVA has a market cap of 3.2B. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while PRVA trades at $25.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas PRVA's P/E ratio is 159.38. In terms of profitability, CERN's ROE is +0.14%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, CERN is less volatile compared to PRVA. This indicates lower risk in terms of short-term price fluctuations for CERN.Check PRVA's competition here
Progyny, Inc. (NASDAQ: PGNY)
CERN vs PGNY Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, PGNY has a market cap of 2.4B. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while PGNY trades at $31.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas PGNY's P/E ratio is 22.77. In terms of profitability, CERN's ROE is +0.14%, compared to PGNY's ROE of +0.13%. Regarding short-term risk, CERN is less volatile compared to PGNY. This indicates lower risk in terms of short-term price fluctuations for CERN.Check PGNY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
CERN vs HTFL Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, HTFL has a market cap of 2.1B. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while HTFL trades at $24.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas HTFL's P/E ratio is -12.00. In terms of profitability, CERN's ROE is +0.14%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, CERN is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for CERN.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
CERN vs WGS Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, WGS has a market cap of 1.8B. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while WGS trades at $59.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas WGS's P/E ratio is 69.53. In terms of profitability, CERN's ROE is +0.14%, compared to WGS's ROE of -0.28%. Regarding short-term risk, CERN is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for CERN.Check WGS's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
CERN vs NXGN Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas NXGN's P/E ratio is -266.00. In terms of profitability, CERN's ROE is +0.14%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, CERN is less volatile compared to NXGN. This indicates lower risk in terms of short-term price fluctuations for CERN.Check NXGN's competition here
Teladoc Health, Inc. (NYSE: TDOC)
CERN vs TDOC Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, TDOC has a market cap of 1.6B. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while TDOC trades at $8.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas TDOC's P/E ratio is -9.75. In terms of profitability, CERN's ROE is +0.14%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, CERN is less volatile compared to TDOC. This indicates lower risk in terms of short-term price fluctuations for CERN.Check TDOC's competition here
Agiliti, Inc. (NYSE: AGTI)
CERN vs AGTI Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas AGTI's P/E ratio is -71.79. In terms of profitability, CERN's ROE is +0.14%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, CERN is less volatile compared to AGTI. This indicates lower risk in terms of short-term price fluctuations for CERN.Check AGTI's competition here
Omada Health (NASDAQ: OMDA)
CERN vs OMDA Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, OMDA has a market cap of 1.2B. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while OMDA trades at $20.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas OMDA's P/E ratio is 293.29. In terms of profitability, CERN's ROE is +0.14%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, CERN is less volatile compared to OMDA. This indicates lower risk in terms of short-term price fluctuations for CERN.Check OMDA's competition here
Certara, Inc. (NASDAQ: CERT)
CERN vs CERT Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, CERT has a market cap of 1.2B. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while CERT trades at $7.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas CERT's P/E ratio is 19.26. In terms of profitability, CERN's ROE is +0.14%, compared to CERT's ROE of -0.01%. Regarding short-term risk, CERN is less volatile compared to CERT. This indicates lower risk in terms of short-term price fluctuations for CERN.Check CERT's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
CERN vs GDRX Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, GDRX has a market cap of 1B. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while GDRX trades at $2.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas GDRX's P/E ratio is 8.97. In terms of profitability, CERN's ROE is +0.14%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, CERN is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for CERN.Check GDRX's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
CERN vs CCLDO Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas CCLDO's P/E ratio is N/A. In terms of profitability, CERN's ROE is +0.14%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, CERN is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for CERN.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
CERN vs HSTM Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, HSTM has a market cap of 792.8M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while HSTM trades at $27.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas HSTM's P/E ratio is 35.70. In terms of profitability, CERN's ROE is +0.14%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, CERN is less volatile compared to HSTM. This indicates lower risk in terms of short-term price fluctuations for CERN.Check HSTM's competition here
Phreesia, Inc. (NYSE: PHR)
CERN vs PHR Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, PHR has a market cap of 632.6M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while PHR trades at $10.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas PHR's P/E ratio is 36.55. In terms of profitability, CERN's ROE is +0.14%, compared to PHR's ROE of +0.03%. Regarding short-term risk, CERN is less volatile compared to PHR. This indicates lower risk in terms of short-term price fluctuations for CERN.Check PHR's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
CERN vs MPLN-WT Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, CERN's ROE is +0.14%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, CERN is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for CERN.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
CERN vs ACCD Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas ACCD's P/E ratio is -3.08. In terms of profitability, CERN's ROE is +0.14%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, CERN is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for CERN.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
CERN vs SHCR Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas SHCR's P/E ratio is -3.76. In terms of profitability, CERN's ROE is +0.14%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, CERN is less volatile compared to SHCR. This indicates lower risk in terms of short-term price fluctuations for CERN.Check SHCR's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
CERN vs WGSWW Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, WGSWW has a market cap of 514.5M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas WGSWW's P/E ratio is N/A. In terms of profitability, CERN's ROE is +0.14%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, CERN is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for CERN.Check WGSWW's competition here
Evolent Health, Inc. (NYSE: EVH)
CERN vs EVH Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, EVH has a market cap of 474.7M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while EVH trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas EVH's P/E ratio is 422.00. In terms of profitability, CERN's ROE is +0.14%, compared to EVH's ROE of -0.78%. Regarding short-term risk, CERN is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for CERN.Check EVH's competition here
NRC Health (NASDAQ: NRC)
CERN vs NRC Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, NRC has a market cap of 474.2M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while NRC trades at $21.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas NRC's P/E ratio is 25.66. In terms of profitability, CERN's ROE is +0.14%, compared to NRC's ROE of +0.57%. Regarding short-term risk, CERN is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for CERN.Check NRC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
CERN vs SLGCW Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, CERN's ROE is +0.14%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, CERN is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for CERN.Check SLGCW's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
CERN vs SLGC Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas SLGC's P/E ratio is -3.04. In terms of profitability, CERN's ROE is +0.14%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, CERN is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for CERN.Check SLGC's competition here
TruBridge, Inc. (NASDAQ: TBRG)
CERN vs TBRG Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas TBRG's P/E ratio is 9.37. In terms of profitability, CERN's ROE is +0.14%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, CERN is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for CERN.Check TBRG's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
CERN vs SOPH Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, SOPH has a market cap of 393.2M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while SOPH trades at $5.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas SOPH's P/E ratio is -11.00. In terms of profitability, CERN's ROE is +0.14%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, CERN is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for CERN.Check SOPH's competition here
MultiPlan Corporation (NYSE: MPLN)
CERN vs MPLN Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas MPLN's P/E ratio is -0.23. In terms of profitability, CERN's ROE is +0.14%, compared to MPLN's ROE of +2.06%. Regarding short-term risk, CERN is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for CERN.Check MPLN's competition here
Simulations Plus, Inc. (NASDAQ: SLP)
CERN vs SLP Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, SLP has a market cap of 370.9M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while SLP trades at $18.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas SLP's P/E ratio is 20.84. In terms of profitability, CERN's ROE is +0.14%, compared to SLP's ROE of +0.06%. Regarding short-term risk, CERN is less volatile compared to SLP. This indicates lower risk in terms of short-term price fluctuations for CERN.Check SLP's competition here
Claritev Corporation (NYSE: CTEV)
CERN vs CTEV Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, CTEV has a market cap of 369.3M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while CTEV trades at $21.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas CTEV's P/E ratio is -1.66. In terms of profitability, CERN's ROE is +0.14%, compared to CTEV's ROE of +2.06%. Regarding short-term risk, CERN is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for CERN.Check CTEV's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
CERN vs TRHC Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas TRHC's P/E ratio is -4.27. In terms of profitability, CERN's ROE is +0.14%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, CERN is less volatile compared to TRHC. This indicates lower risk in terms of short-term price fluctuations for CERN.Check TRHC's competition here
So-Young International Inc. (NASDAQ: SY)
CERN vs SY Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, SY has a market cap of 253.2M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while SY trades at $1.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas SY's P/E ratio is -5.85. In terms of profitability, CERN's ROE is +0.14%, compared to SY's ROE of -0.16%. Regarding short-term risk, CERN is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for CERN.Check SY's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
CERN vs SMFR Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas SMFR's P/E ratio is N/A. In terms of profitability, CERN's ROE is +0.14%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, CERN is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for CERN.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
CERN vs SPOK Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, SPOK has a market cap of 221.2M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while SPOK trades at $10.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas SPOK's P/E ratio is 17.65. In terms of profitability, CERN's ROE is +0.14%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, CERN is less volatile compared to SPOK. This indicates lower risk in terms of short-term price fluctuations for CERN.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
CERN vs AMWL Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, AMWL has a market cap of 179.4M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while AMWL trades at $10.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas AMWL's P/E ratio is -2.07. In terms of profitability, CERN's ROE is +0.14%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, CERN is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for CERN.Check AMWL's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
CERN vs HCAT Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, HCAT has a market cap of 153.7M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while HCAT trades at $2.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas HCAT's P/E ratio is 10.40. In terms of profitability, CERN's ROE is +0.14%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, CERN is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for CERN.Check HCAT's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
CERN vs CPSI Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas CPSI's P/E ratio is -183.80. In terms of profitability, CERN's ROE is +0.14%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, CERN is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for CERN.Check CPSI's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
CERN vs OPRX Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, OPRX has a market cap of 117.1M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while OPRX trades at $6.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas OPRX's P/E ratio is 5.72. In terms of profitability, CERN's ROE is +0.14%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, CERN is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for CERN.Check OPRX's competition here
Augmedix, Inc. (NASDAQ: AUGX)
CERN vs AUGX Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas AUGX's P/E ratio is -4.99. In terms of profitability, CERN's ROE is +0.14%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, CERN is less volatile compared to AUGX. This indicates lower risk in terms of short-term price fluctuations for CERN.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
CERN vs CCLD Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, CCLD has a market cap of 94.3M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while CCLD trades at $2.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas CCLD's P/E ratio is 8.22. In terms of profitability, CERN's ROE is +0.14%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, CERN is less volatile compared to CCLD. This indicates lower risk in terms of short-term price fluctuations for CERN.Check CCLD's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
CERN vs DH Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, DH has a market cap of 72.4M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while DH trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas DH's P/E ratio is 2.64. In terms of profitability, CERN's ROE is +0.14%, compared to DH's ROE of -0.67%. Regarding short-term risk, CERN is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for CERN.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
CERN vs FORA Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas FORA's P/E ratio is -24.11. In terms of profitability, CERN's ROE is +0.14%, compared to FORA's ROE of -0.17%. Regarding short-term risk, CERN is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for CERN.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
CERN vs CCLDP Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas CCLDP's P/E ratio is N/A. In terms of profitability, CERN's ROE is +0.14%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, CERN is less volatile compared to CCLDP. This indicates lower risk in terms of short-term price fluctuations for CERN.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
CERN vs ONMD Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, ONMD has a market cap of 35M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while ONMD trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas ONMD's P/E ratio is -4.10. In terms of profitability, CERN's ROE is +0.14%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, CERN is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for CERN.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
CERN vs SNCE Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas SNCE's P/E ratio is -0.27. In terms of profitability, CERN's ROE is +0.14%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, CERN is less volatile compared to SNCE. This indicates lower risk in terms of short-term price fluctuations for CERN.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
CERN vs AKLI Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas AKLI's P/E ratio is -0.71. In terms of profitability, CERN's ROE is +0.14%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, CERN is less volatile compared to AKLI. This indicates lower risk in terms of short-term price fluctuations for CERN.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
CERN vs SHLT Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas SHLT's P/E ratio is -3.87. In terms of profitability, CERN's ROE is +0.14%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, CERN is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for CERN.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
CERN vs SHCRW Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, CERN's ROE is +0.14%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, CERN is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for CERN.Check SHCRW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
CERN vs EUDA Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, EUDA has a market cap of 28M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while EUDA trades at $14.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas EUDA's P/E ratio is -28.30. In terms of profitability, CERN's ROE is +0.14%, compared to EUDA's ROE of +0.70%. Regarding short-term risk, CERN is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for CERN.Check EUDA's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
CERN vs ONMDW Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, ONMDW has a market cap of 27.8M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas ONMDW's P/E ratio is N/A. In terms of profitability, CERN's ROE is +0.14%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, CERN is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for CERN.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
CERN vs STRM Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas STRM's P/E ratio is -2.40. In terms of profitability, CERN's ROE is +0.14%, compared to STRM's ROE of -0.32%. Regarding short-term risk, CERN is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for CERN.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
CERN vs RNLX Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas RNLX's P/E ratio is -0.33. In terms of profitability, CERN's ROE is +0.14%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, CERN is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for CERN.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
CERN vs LIFW Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas LIFW's P/E ratio is -0.02. In terms of profitability, CERN's ROE is +0.14%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, CERN is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for CERN.Check LIFW's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
CERN vs BEATW Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, BEATW has a market cap of 15.9M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while BEATW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas BEATW's P/E ratio is -0.04. In terms of profitability, CERN's ROE is +0.14%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, CERN is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for CERN.Check BEATW's competition here
Babylon Holdings Limited (NYSE: BBLN)
CERN vs BBLN Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas BBLN's P/E ratio is -0.04. In terms of profitability, CERN's ROE is +0.14%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, CERN is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for CERN.Check BBLN's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
CERN vs ETAO Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas ETAO's P/E ratio is -0.01. In terms of profitability, CERN's ROE is +0.14%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, CERN is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for CERN.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
CERN vs BFRG Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, BFRG has a market cap of 7.1M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while BFRG trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas BFRG's P/E ratio is -1.12. In terms of profitability, CERN's ROE is +0.14%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, CERN is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for CERN.Check BFRG's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
CERN vs SCNX Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, SCNX has a market cap of 5.7M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while SCNX trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas SCNX's P/E ratio is -0.15. In terms of profitability, CERN's ROE is +0.14%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, CERN is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for CERN.Check SCNX's competition here
UpHealth, Inc. (NYSE: UPH)
CERN vs UPH Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas UPH's P/E ratio is -0.07. In terms of profitability, CERN's ROE is +0.14%, compared to UPH's ROE of -1.05%. Regarding short-term risk, CERN is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for CERN.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
CERN vs UPH-WT Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, CERN's ROE is +0.14%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, CERN is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for CERN.Check UPH-WT's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
CERN vs MGRX Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, MGRX has a market cap of 5.3M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while MGRX trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas MGRX's P/E ratio is -0.39. In terms of profitability, CERN's ROE is +0.14%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, CERN is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for CERN.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
CERN vs PEARW Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas PEARW's P/E ratio is -0.00. In terms of profitability, CERN's ROE is +0.14%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, CERN is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for CERN.Check PEARW's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
CERN vs PEAR Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas PEAR's P/E ratio is -0.08. In terms of profitability, CERN's ROE is +0.14%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, CERN is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for CERN.Check PEAR's competition here
Ontrak, Inc. (NASDAQ: OTRK)
CERN vs OTRK Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas OTRK's P/E ratio is -0.02. In terms of profitability, CERN's ROE is +0.14%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, CERN is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for CERN.Check OTRK's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
CERN vs HCTI Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, HCTI has a market cap of 1.9M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while HCTI trades at $1.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas HCTI's P/E ratio is -0.21. In terms of profitability, CERN's ROE is +0.14%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, CERN is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for CERN.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
CERN vs CMAX Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas CMAX's P/E ratio is -0.00. In terms of profitability, CERN's ROE is +0.14%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, CERN is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for CERN.Check CMAX's competition here
Aclarion, Inc. (NASDAQ: ACON)
CERN vs ACON Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while ACON trades at $2.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas ACON's P/E ratio is -0.23. In terms of profitability, CERN's ROE is +0.14%, compared to ACON's ROE of -0.54%. Regarding short-term risk, CERN is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for CERN.Check ACON's competition here
VSee Health, Inc. (NASDAQ: VSEE)
CERN vs VSEE Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, VSEE has a market cap of 1.3M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while VSEE trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas VSEE's P/E ratio is -0.15. In terms of profitability, CERN's ROE is +0.14%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, CERN is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for CERN.Check VSEE's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
CERN vs VSEEW Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, VSEEW has a market cap of 1.3M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, CERN's ROE is +0.14%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, CERN is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for CERN.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
CERN vs LIFWZ Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, CERN's ROE is +0.14%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, CERN is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for CERN.Check LIFWZ's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
CERN vs EUDAW Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, EUDAW has a market cap of 922.5K. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, CERN's ROE is +0.14%, compared to EUDAW's ROE of +0.70%. Regarding short-term risk, CERN is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for CERN.Check EUDAW's competition here
SCWorx Corp. (NASDAQ: WORX)
CERN vs WORX Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, WORX has a market cap of 629.5K. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while WORX trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas WORX's P/E ratio is -0.69. In terms of profitability, CERN's ROE is +0.14%, compared to WORX's ROE of -0.65%. Regarding short-term risk, CERN is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for CERN.Check WORX's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
CERN vs MSPRZ Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, CERN's ROE is +0.14%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, CERN is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for CERN.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERN)
CERN vs KERN Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas KERN's P/E ratio is -0.01. In terms of profitability, CERN's ROE is +0.14%, compared to KERN's ROE of -0.17%. Regarding short-term risk, CERN is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for CERN.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
CERN vs KERNW Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas KERNW's P/E ratio is -0.00. In terms of profitability, CERN's ROE is +0.14%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, CERN is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for CERN.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
CERN vs LIFWW Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas LIFWW's P/E ratio is N/A. In terms of profitability, CERN's ROE is +0.14%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, CERN is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for CERN.Check LIFWW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
CERN vs ZCMD Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, ZCMD has a market cap of 48.6K. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while ZCMD trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas ZCMD's P/E ratio is -0.05. In terms of profitability, CERN's ROE is +0.14%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, CERN is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for CERN.Check ZCMD's competition here
CareMax, Inc. (NASDAQ: CMAXW)
CERN vs CMAXW Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas CMAXW's P/E ratio is N/A. In terms of profitability, CERN's ROE is +0.14%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, CERN is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for CERN.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
CERN vs ACONW Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, ACONW has a market cap of 11.9K. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas ACONW's P/E ratio is N/A. In terms of profitability, CERN's ROE is +0.14%, compared to ACONW's ROE of -0.54%. Regarding short-term risk, CERN is less volatile compared to ACONW. This indicates lower risk in terms of short-term price fluctuations for CERN.Check ACONW's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
CERN vs MTBCO Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas MTBCO's P/E ratio is N/A. In terms of profitability, CERN's ROE is +0.14%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, CERN is less volatile compared to MTBCO. This indicates lower risk in terms of short-term price fluctuations for CERN.Check MTBCO's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
CERN vs MSPRV Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas MSPRV's P/E ratio is N/A. In terms of profitability, CERN's ROE is +0.14%, compared to MSPRV's ROE of N/A. Regarding short-term risk, CERN is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for CERN.Check MSPRV's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
CERN vs MTBCP Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas MTBCP's P/E ratio is N/A. In terms of profitability, CERN's ROE is +0.14%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, CERN is less volatile compared to MTBCP. This indicates lower risk in terms of short-term price fluctuations for CERN.Check MTBCP's competition here
CareCloud, Inc. (NASDAQ: MTBC)
CERN vs MTBC Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, MTBC has a market cap of 0. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas MTBC's P/E ratio is N/A. In terms of profitability, CERN's ROE is +0.14%, compared to MTBC's ROE of +0.17%. Regarding short-term risk, CERN is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for CERN.Check MTBC's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
CERN vs CHNG Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, CHNG has a market cap of 0. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas CHNG's P/E ratio is -152.72. In terms of profitability, CERN's ROE is +0.14%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, CERN is less volatile compared to CHNG. This indicates lower risk in terms of short-term price fluctuations for CERN.Check CHNG's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
CERN vs CHNGU Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas CHNGU's P/E ratio is N/A. In terms of profitability, CERN's ROE is +0.14%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, CERN is less volatile compared to CHNGU. This indicates lower risk in terms of short-term price fluctuations for CERN.Check CHNGU's competition here
Cue Health Inc. (NASDAQ: HLTH)
CERN vs HLTH Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, HLTH has a market cap of 0. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while HLTH trades at $25.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas HLTH's P/E ratio is N/A. In terms of profitability, CERN's ROE is +0.14%, compared to HLTH's ROE of +0.00%. Regarding short-term risk, CERN is less volatile compared to HLTH. This indicates lower risk in terms of short-term price fluctuations for CERN.Check HLTH's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
CERN vs NAVA Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, NAVA has a market cap of 0. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas NAVA's P/E ratio is N/A. In terms of profitability, CERN's ROE is +0.14%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, CERN is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for CERN.Check NAVA's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
CERN vs CNVY Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, CNVY has a market cap of 0. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas CNVY's P/E ratio is -71.50. In terms of profitability, CERN's ROE is +0.14%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, CERN is less volatile compared to CNVY. This indicates lower risk in terms of short-term price fluctuations for CERN.Check CNVY's competition here
Castlight Health, Inc. (NYSE: CSLT)
CERN vs CSLT Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, CSLT has a market cap of 0. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas CSLT's P/E ratio is -37.27. In terms of profitability, CERN's ROE is +0.14%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, CERN is less volatile compared to CSLT. This indicates lower risk in terms of short-term price fluctuations for CERN.Check CSLT's competition here
NantHealth, Inc. (NASDAQ: NH)
CERN vs NH Comparison July 2026
Cerner Corporation (NASDAQ: CERN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CERN stands at 0. In comparison, NH has a market cap of 0. Regarding current trading prices, CERN is priced at $94.92 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CERN currently has a P/E ratio of 55.84, whereas NH's P/E ratio is -0.12. In terms of profitability, CERN's ROE is +0.14%, compared to NH's ROE of +0.35%. Regarding short-term risk, CERN is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for CERN.Check NH's competition here